Susan Molineaux does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Theravance Biopharma, Inc., GERON CORP, Cyteir Therapeutics, Inc., Calithera Biosciences, Inc., and Repare Therapeutics Inc..
2015 was Susan Molineaux's most active year for acquiring shares with 12 total transactions. Susan Molineaux's most active month to acquire stocks was the month of April. 2015 was Susan Molineaux's most active year for disposing of shares, totalling 8 transactions. Susan Molineaux's most active month to dispose stocks was the month of November. 2015 saw Susan Molineaux paying a total of $151,415.76 for 384,458 shares, this is the most they've acquired in one year. In 2023 Susan Molineaux cashed out on 70,000 shares for a total of $86,800.00, their largest year based on trade value.